GLO1 and type 2 diabetes mellitus: This study represents the first comprehensive, cross-sectional investigation indicating a potential link between the GLO1 polymorphism and diabetic neuropathy in patients with type 2 diabetes mellitus, displaying the involvement of methylglyoxal in the pathogenesis of diabetic neuropathy, particularly in type 2 diabetes mellitus.